Written question asked by Preet Kaur Gill (Labour) on Friday, 21 April 2023, in the House of Commons. It was due for an answer on Tuesday, 25 April 2023. It was answered by Maria Caulfield (Conservative) on Friday, 28 April 2023 on behalf of the Department of Health and Social Care.
Coronavirus: Drugs
- Question
-
To ask the Secretary of State for Health and Social Care, whether his Department has made a recent assessment of the effectiveness of the NICE guidelines that were issued following the outbreak of covid-19 in respect of drugs that cause respiratory depression.
- Answer
-
The National Institute for Health and Care Excellence has made no recent assessment of the effectiveness of its guidelines that were issued following the outbreak of COVID-19 in respect of drugs that cause respiratory depression.
Secondary information
- Type
- Written question
- Reference
- 182185
- Session
- 2022-23
- Subjects
- Drugs National Institute for Health and Care Excellence Standards Side effects Respiratory system Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-04-28 15:15:27 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/182185
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/182185
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/182185